Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized open-label pharmacokinetic/pharmacodynamic study of NOMAC-E2 versus ENG-E2 vaginal rings
NL-OMON35882Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nomegestrol, estradiol and etonogestrel in contraception, sponsored by Merck & Co. Primary endpoints: Pharmacokinetics of estradiol, nomegestrol acetate, and etonogestrel and Effect on ovarian function. Started Aug 2011; status: active, not recruiting.
02
Drugs
nomegestrolestradioletonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON35882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35882.